Clinical Trial Update: Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 randomized trial in second-line multiple myeloma comparing lenalidomide with low-dose dexamethasone to lenalidomide alone; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Dexamethasone (low-dose) (dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED